Preliminary Evaluation of a COWP-targeting TaqMan Real-time PCR Assay in Fecal Samples from Young Ruminants in Tunisia: An Exploratory Study

R
Rafik Aloulou3
S
Sihem Hamdi4
A
Aymen Mamlouk4
W
Wissal Derouich1
A
Amal Flijane3
1National Gene Bank of Tunisia, Ministry of Environment, Charguia 1, Tunis, Tunisia.
2Research Laboratory “Ecosystems, Aquatic and Animal Resources” (LR21AGR01), University of Carthage, Tunisia.
3ISA-Chott-Mariem, Institution of Agricultural Research and Higher Education, Tunisia.
4National School of Veterinary Medicine, Sidi Thabet, University of Manouba, Tunisia.

Background: Molecular assays can support the detection of Cryptosporidium in animal fecal samples. This exploratory study evaluated amplification obtained using a COWP-targeting TaqMan real-time PCR assay in fecal samples from young cattle and sheep in Tunisia.

Methods: Twelve fecal samples collected previously from six Holstein calves and six Barbarine sheep at the National School of Veterinary Medicine of Sidi Thabet, Tunisia, were analyzed. Laboratory work was conducted at the National Gene Bank of Tunisia in 2026. DNA was extracted using a modified cetyltrimethylammonium bromide (CTAB) procedure incorporating liquid-nitrogen pretreatment. A TaqMan real-time PCR assay targeting the COWP gene was performed with an internal process control (IPC). An exploratory DNA concentration series was also examined.

Result: Three of the 12 samples showed amplification meeting the operational cycle-threshold criterion (Ct < 40). The samples originated from two calves aged 7 and 10 days and one 10-day-old sheep, with Ct values of 33.85, 35.81 and 38.80, respectively. All three animals had recorded diarrhea. Four samples from clinically normal sheep were negative. The concentration-series observations did not establish a formal analytical limit of detection or complete analytical validation. In the absence of independent molecular confirmation, definitive species identification could not be established.

Cryptosporidium is a genus of apicomplexan parasites that infect the gastrointestinal tract of humans and a wide range of animals. Infection may cause diarrhea, with clinical severity influenced by factors including host age, immune status, parasite species and infection intensity. Young ruminants are of particular interest because enteric disease can affect animal health and farm productivity. Some Cryptosporidium species are zoonotic, making accurate detection and characterization relevant to veterinary and public health (Fayer, 2004; Ryan et al., 2014; Ryan et al., 2021). Studies in young ruminants have also documented the occurrence of Cryptosporidium and used molecular approaches to characterize the detected species, highlighting the relevance of age-specific investigations and molecular confirmation (Dixit et al., 2018; Swain et al., 2018).
       
Recent studies continue to document the occurrence and zoonotic potential of Cryptosporidium spp. in different animal hosts. For example, Jian et al., (2025) investigated Cryptosporidium spp. and Enterocytozoon bieneusi in dogs and cats, while Mishra et al., (2025) examined naturally occurring Cryptosporidium spp. infections in goats. These studies highlight the importance of investigating the parasite in different animal populations and epidemiological contexts.
       
The diagnosis of cryptosporidiosis may involve microscopic examination, antigen detection and molecular methods. Polymerase chain reaction (PCR)-based approaches are increasingly used in veterinary investigations for the molecular detection of infectious agents, including multiplex PCR assays developed for the diagnosis of infections in cattle (Narwade et al., 2026). Real-time PCR (qPCR) offers a sensitive approach for detecting target nucleic acids and can be used in diagnostic workflows. TaqMan assays use a sequence-specific fluorescent probe, allowing amplification to be monitored during the reaction. The performance of such assays, however, depends on the target selected, primer and probe specificity, sample preparation, the presence of inhibitors and the quality of analytical validation. The diagnostic performance of molecular methods can be influenced by fecal-matrix inhibitors, DNA extraction procedures and the analytical characteristics of the assay; consequently, the choice of diagnostic method should be considered when interpreting results from animal samples (Aboelsoued and Abdel, 2022).
       
The Cryptosporidium oocyst wall protein gene (COWP) has been used as a molecular target in diagnostic assays. Several genetic targets have been used for the molecular detection and characterization of Cryptosporidium, including the COWP gene and the small-subunit ribosomal RNA (18S rRNA) gene. The suitability of a target depends on the diagnostic objective, the sequence region selected and the ability of the assay to detect or differentiate the species of interest (Xiao et al., 2004; Ryan et al., 2014). Shin et al., (2018) described a multiplex real-time PCR approach targeting several intestinal parasites and incorporating an internal control. Nevertheless, amplification of a COWP-associated target should not automatically be interpreted as definitive identification of Cryptosporidium parvum in the absence of appropriate evidence for species specificity or independent confirmation.
       
Fecal samples also present methodological challenges for molecular analysis. Their composition may vary considerably and substances present in feces can interfere with nucleic-acid amplification. An internal amplification control can help identify possible inhibition, although its interpretation depends on how the control is introduced and measured. Sample extraction procedures and analytical controls therefore need to be considered when interpreting qPCR results. The present study was designed as an exploratory evaluation of a TaqMan real-time PCR assay targeting the COWP gene in fecal samples collected from young cattle and sheep in Tunisia, including animals with diarrhea and clinically normal sheep.
       
The objectives were to examine whether target amplification could be detected in these samples, document the corresponding cycle-threshold values and describe the results of the internal control and an exploratory concentration series. The study was not designed to estimate population prevalence or to establish a complete analytical validation of the assay.
Study design and fecal samples
 
This exploratory investigation was conducted in 2026 at the National Gene Bank of Tunisia using 12 fecal samples previously collected at the National School of Veterinary Medicine of Sidi Thabet, Tunisia. The samples comprised six male Holstein calves aged 2-10 days and six Barbarine sheep aged 7-120 days. According to the original clinical questionnaires, eight animals presented with diarrhea, whereas four sheep (samples 1, 2, 11 and 12) had no reported clinical signs and were recorded as clinically normal. Additional clinical observations included yellow diarrhea in calf sample 4 and bloody diarrhea in calf sample 6. The molecular analyses were conducted at the National Gene Bank of Tunisia. The individual sample characteristics and corresponding PCR results are presented in Table 1.

Table 1: Characteristics of the fecal samples and results of the COWP-targeting TaqMan real-time PCR assay.


 
DNA extraction and internal control
 
DNA extraction was performed using a modified cetyltrimethylammonium bromide (CTAB) protocol adapted from Doyle and Doyle (1987), with modifications to accommodate fecal samples. Liquid-nitrogen pretreatment was incorporated into the extraction procedure.
       
An internal process control (IPC) was added before DNA extraction. For this purpose, 5 µL of the control preparation at 0.2 ng/µL was added to each sample. The IPC was subsequently monitored during real-time PCR to assess whether amplification of the control target could be detected in the extracts.
       
A separate reference control containing a known quantity of DNA was processed through the extraction procedure. DNA concentration was assessed using a NanoDrop spectrophotometer. Because this measurement does not specifically quantify the IPC target or Cryptosporidium DNA, it was not used to establish parasite-DNA recovery or IPC recovery. The IPC results were interpreted as evidence of control-target amplification rather than as a direct measure of extraction efficiency.
 
TaqMan real-time PCR assay
 
Real-time PCR was performed using a TaqMan assay targeting the Cryptosporidium oocyst wall protein (COWP) gene. The assay was based on the primer/probe approach described by Shin et al., (2018), with the target sequence referenced to GenBank accession AB089292.
The oligonucleotide sequences were as follows:
 
• Forward primer: CAA GGC CTC CAA TGT ATA CAA AC
 
•​ Reverse primer: CGA TTG CTT GGA CTG AAA TAC AG
 
•​ TaqMan probe: FAM-CCT GTC TGC CCT CCA GGT ACA  GTA TTA C-BHQ1
       
The assay was adapted to the reaction conditions and internal-control system used in the present study. Each reaction had a final volume of 20 µL and contained 4 µL of 5× HOT FIREPol Multiplex qPCR Mix with ROX, 2 µL of 10× Oligo/Probe Mix, 2 µL of 10× Universal IPC Oligo/Probe Mix, 2 ng of template DNA and nuclease-free water to the final volume.
       
The amplification program consisted of an initial step at 95°C for 10 min, followed by 40 cycles of denaturation at 95°C for 15 s and annealing/extension at 60°C for 60 s. Fluorescence was recorded during the extension step.
       
The initial real-time PCR analysis included the 12 fecal samples, a positive control containing C. parvum DNA, a no-template control (NTC) and an internal process control (IPC). A Ct value below 40 was used as the operational criterion for positive amplification. Results were interpreted in conjunction with the available controls and the exploratory design of the study.
       
Additional laboratory procedures were performed on selected samples and included further DNA extraction, PCR analyses and evaluation of the internal process control (IPC). These complementary procedures were conducted to further examine the performance of the assay and the amplification of the target and control sequences. The positive control containing C. parvum DNA was used to monitor target amplification, while the no-template control (NTC) was included to monitor potential contamination. The results presented in this study are based on the initial PCR analysis, with the additional laboratory procedures providing complementary information on the assay and internal control performance.
 
Exploratory concentration series
 
A concentration series was examined to observe amplification across the tested DNA concentrations. The available concentration and Ct records are presented in Table 2. These observations are reported descriptively. Because the underlying calibration output needed to independently verify the regression statistics and analytical detection limit is not available for this version of the manuscript, the concentration series is not used here to claim a fully established analytical limit of detection, amplification efficiency, or linearity.

Table 2: Available observations from the exploratory DNA concentration series.


 
Data analysis
 
The results were summarized descriptively. The number and proportion of samples showing target amplification were calculated for the complete sample set and separately for calves and sheep. These proportions represent the observed amplification results in the 12 samples analyzed and were not interpreted as estimates of infection prevalence in the wider animal populations. Given the small sample size and exploratory study design, no inferential statistical analysis or population-level prevalence estimate was attempted.
Detection of the COWP-associated target
 
Amplification meeting the study’s operational Ct criterion (Ct < 40) was observed in three of the 12 fecal samples (25%). The positive samples originated from two Holstein calves aged 7 and 10 days and one Barbarine sheep aged 10 days, with Ct values of 33.85, 35.81 and 38.80, respectively (Table 1). All three positive samples came from animals with recorded diarrhea. The four samples obtained from sheep without reported clinical signs were negative. These findings describe the amplification results observed in the sampled animals and do not establish a causal relationship between the detected target and diarrhea. Moreover, amplification with the COWP-targeting assay does not independently confirm the identity of the detected organism at the species level. The diversity of Cryptosporidium species and genotypes reported in humans and animals reinforces the importance of appropriate molecular confirmation when species-level identification is intended (Fayer, 2004; Ryan et al., 2014). Previous studies have investigated Cryptosporidium in young ruminants using different diagnostic and molecular approaches, including molecular characterization in goat kids (Dixit et al., 2018) and buffalo calves (Swain et al., 2018). More recently, Mishra et al., (2025) documented Cryptosporidium infection in goats, further illustrating the continued veterinary relevance of this parasite. However, differences in host species, sample sizes, sampling strategies and diagnostic methods preclude direct comparison of these findings with the amplification proportions observed in the present exploratory sample set.
       
Within the six calf samples, two showed amplification (33.3%). Within the six sheep samples, one showed amplification (16.7%). These proportions describe only the animals included in this small sample set. They should not be interpreted as estimates of infection prevalence in the wider cattle or sheep populations in Tunisia.
       
The observed Ct values were relatively high, particularly for sample 9. A Ct value reflects the point at which fluorescence crosses the defined threshold under a particular assay setup; it should not be interpreted directly as a measure of parasite burden without an appropriate calibration and validation framework. The results are therefore reported as observed amplification values rather than as quantitative estimates of parasite load. The positive control showed amplification, whereas the no-template control (NTC) showed no amplification.
 
Internal process control results
 
The internal process control (IPC) yielded Ct values ranging from 17.3 to 20.7 across the extracts. Detection of the IPC indicates that the control target could be amplified in the tested reactions. These results provide useful information when considering possible amplification inhibition.
       
However, the IPC results do not, by themselves, establish the extraction efficiency for Cryptosporidium oocysts or demonstrate the recovery of parasite DNA from feces. Such conclusions would require a suitable extraction control design and a documented recovery assessment. The separate reference-control recovery estimates obtained from NanoDrop measurements are not interpreted as direct measurements of IPC recovery.
 
Interpretation of the exploratory concentration series
 
The available concentration series showed recorded Ct values across several DNA concentrations, as reported in Table 2. The lowest concentration tested, 0.002 ng/µL, was recorded as not detected (ND), whereas amplification was observed at concentrations of 0.004 ng/µL and above. These findings describe the amplification pattern under the conditions tested but do not establish a formal analytical limit of detection. Such a limit requires a defined validation procedure, sufficient replicate testing at relevant low concentrations and documented detection criteria. Similarly, amplification efficiency, linearity, slope and coefficient of determination cannot be reliably established without the underlying calibration data and appropriate statistical analysis. Accordingly, the concentration-series results are interpreted descriptively and are not used to claim a validated analytical limit of detection or complete analytical performance.
 
Assay specificity and species-level interpretation
 
The assay targeted the COWP gene and included a positive control containing C. parvum DNA. However, the use of this target and positive control does not establish species-specific detection of C. parvum. The primer/probe set used in this study was not experimentally assessed against other Cryptosporidium species or relevant non-target organisms. Furthermore, no independent molecular confirmation, sequencing, or parallel assay targeting a second locus was available for the three positive fecal samples. Accordingly, the results are interpreted as amplification of the COWP-associated target and cannot be considered definitive species-level identification or used to distinguish C. parvum from other Cryptosporidium species.
       
Future investigations should include an independent molecular target, such as a suitably validated 18S rRNA assay and/or sequencing of the relevant amplicon, where appropriate. The specificity of the assay should also be assessed against relevant non-target organisms. The 18S rRNA gene is widely used in Cryptosporidium molecular studies because it contains conserved and variable regions that can support detection and taxonomic characterization. However, its suitability for species discrimination depends on the selected region, primer design and analytical approach. Therefore, an 18S rRNA assay would provide an independent line of evidence but would not automatically guarantee species-level identification.
 
Methodological considerations and study limitations
 
The modified CTAB extraction procedure was used to obtain DNA from fecal material, with liquid-nitrogen pretreatment and an internal process control (IPC) added before DNA extraction. Although CTAB-based extraction methods have been widely used for nucleic-acid isolation, the resistance of Cryptosporidium oocysts to disruption makes it important to assess extraction performance specifically for this organism. The present data do not establish that the extraction procedure achieves a particular level of oocyst disruption or parasite-DNA recovery. The recovery of amplifiable DNA from fecal samples can be affected by the efficiency of oocyst disruption, the quality of the extracted nucleic acids and the presence of substances that inhibit PCR. These factors should therefore be considered when evaluating molecular detection workflows for Cryptosporidium (Jiang et al., 2005; Aboelsoued and Abdel, 2022).
       
The study has several limitations. First, the sample set comprised only 12 animals, which restricts the generalizability of the observed proportions. Second, the positive results were not independently confirmed using a second molecular target or sequencing. Third, the available concentration-series records do not provide a sufficient basis for reporting a complete set of analytical validation parameters. Finally, the sample set included animals with diarrhea and four sheep without reported clinical signs and the study was not designed to assess causal relationships between the detected target and clinical disease.
       
Despite these limitations, the investigation documents the application of a COWP-targeting TaqMan real-time PCR workflow to fecal samples from young cattle and sheep in Tunisia. The findings provide preliminary observations that may inform the design of a larger and more comprehensive evaluation.
In this exploratory study, a TaqMan real-time PCR assay targeting the COWP gene produced detectable amplification in three of 12 fecal samples collected from young ruminants in Tunisia. All three positive samples originated from animals with recorded diarrhea. The internal process control (IPC) yielded Ct values ranging from 17.3 to 20.7 across the extracts, indicating amplification of the control target but not establishing the efficiency of Cryptosporidium oocyst disruption or parasite-DNA recovery. The results demonstrate the feasibility of obtaining target amplification under the conditions used in this investigation, but they do not establish definitive species identification, population prevalence, or complete analytical validation. Further studies should include larger sample sets, independent molecular confirmation, systematic assessment of analytical specificity and a fully documented validation of analytical performance.
The authors would like to express their sincere gratitude to the National Gene Bank of Tunisia, under the supervision of the Ministry of Environment of Tunisia and to the National School of Veterinary Medicine of Sidi Thabet, University of Manouba, Tunisia, for their institutional support and for providing the facilities and resources that contributed to the completion of this study.
 
Disclaimers
 
The views and conclusions expressed in this article are solely those of the authors and do not necessarily represent the views of their affiliated institutions. The authors are responsible for the accuracy and completeness of the information provided, but do not accept any liability for any direct or indirect losses resulting from the use of this content.
 
Informed consent
 
Not applicable.
The authors declare that there are no conflicts of interest regarding the publication of this article. No funding or sponsorship influenced the design of the study, data collection, analysis, decision to publish, or preparation of the manuscript.

  1. Aboelsoued, D. and Abdel, M.K.N. (2022). Diagnosis and control of cryptosporidiosis in farm animals. Journal of Parasitic Diseases. 46(4): 1133-1146. doi: 10.1007/s12639-022-01513-2.

  2. Dixit, P., Rao, M.L.V., Dixit, A.K., Gupta, R. and Shukla, P.C. (2018). Prevalence and molecular characterisation of Cryptosporidium spp. in goat kids. Indian Journal of Animal Research. 53(9): 1234-1238. doi: 10.18805/ijar.B-3642.

  3. Doyle, J.J. and Doyle, J.L. (1987). A rapid DNA isolation procedure for small quantities of fresh leaf tissue. Phytochemical Bulletin. 19(1): 11-15.

  4. Fayer, R. (2004). Cryptosporidium: A water-borne zoonotic parasite. Veterinary Parasitology. 126(1-2): 37-56. doi: 10.1016/ j.vetpar.2004.09.004.

  5. Jiang, J., Alderisio, K.A., Singh, A. and Xiao, L. (2005). Development of procedures for direct extraction of Cryptosporidium DNA from water concentrates and for relief of PCR inhibitors. Applied and Environmental Microbiology. 71(3): 1135-1141. doi: 10.1128/AEM.71.3.1135-1141.2005.

  6. Jian, Y., Liu, S., Han, Q., Song, J., Li, P., Gao, Y., Tu, Y. and Luo, H. (2025). Occurrence and zoonotic evaluation of Cryptosporidium spp. and Enterocytozoon bieneusi in dogs and cats in Wenzhou, Southern China. Indian Journal of Animal Research. 59(8): 1381-1387. doi: 10.18805/IJAR.BF-1987.

  7. Mishra, V.K., Singh, S., Patel, S.K. et al. (2025). Prevalence, risk factors and haemato-biochemical alterations associated with naturally occurring Cryptosporidium spp. infection in goats. Indian Journal of Animal Research. doi: 10.18805/IJAR.B-5641.

  8. Narwade, P.S., Kumar, R.P., Kumar, P.P., Balamurugan, B., Jena, D., Ravi, K.S., Mishra, M.R., Ghosh, M. and Kumar, A. (2026). Prevalence of uterine infections and development of a multiplex PCR assay for their detection in cattle. Indian Journal of Animal Research. 60(2): 292-299. doi: 10.18805/IJAR.B-5720.

  9. Ryan, U., Fayer, R. and Xiao, L. (2014). Cryptosporidium species in humans and animals: Current understanding and research needs. Parasitology. 141(13): 1667-1685. doi: 10.1017/S0031182014001085.

  10. Ryan, U., Zahedi, A., Feng, Y. and Xiao, L. (2021). An update on zoonotic Cryptosporidium species and genotypes in humans. Animals. 11(11): 3307. doi: 10.3390/ani11113307.

  11. Shin, J.H., Lee, S.E., Kim, T.S., Ma, D.W., Cho, S.H., Chai, J.Y. and Shin, E.H. (2018). Development of molecular diagnosis using multiplex real-time PCR and T4 phage internal control to simultaneously detect Cryptosporidium parvum, Giardia lamblia and Cyclospora cayetanensis from human stool samples. The Korean Journal of Parasitology. 56(5): 419-427. doi: 10.3347/kjp.2018.56. 5.419.

  12. Swain, K., Vohra, S., Sangwan, A.K., Routray, A., Panigrahi, S. and Ganguly, S. (2018). Prevalence and molecular characterization of Cryptosporidium species in buffalo calves of western Haryana. Indian Journal of Animal Research. 53(5): 667-671. doi: 10.18805/ijar.B-3568.

  13. Xiao, L., Fayer, R., Ryan, U. and Upton, S.J. (2004). Cryptosporidium taxonomy: Recent advances and implications for public health. Clinical Microbiology Reviews. 17(1): 72-97. doi: 10.1128/CMR.17.1.72-97.2004.

Preliminary Evaluation of a COWP-targeting TaqMan Real-time PCR Assay in Fecal Samples from Young Ruminants in Tunisia: An Exploratory Study

R
Rafik Aloulou3
S
Sihem Hamdi4
A
Aymen Mamlouk4
W
Wissal Derouich1
A
Amal Flijane3
1National Gene Bank of Tunisia, Ministry of Environment, Charguia 1, Tunis, Tunisia.
2Research Laboratory “Ecosystems, Aquatic and Animal Resources” (LR21AGR01), University of Carthage, Tunisia.
3ISA-Chott-Mariem, Institution of Agricultural Research and Higher Education, Tunisia.
4National School of Veterinary Medicine, Sidi Thabet, University of Manouba, Tunisia.

Background: Molecular assays can support the detection of Cryptosporidium in animal fecal samples. This exploratory study evaluated amplification obtained using a COWP-targeting TaqMan real-time PCR assay in fecal samples from young cattle and sheep in Tunisia.

Methods: Twelve fecal samples collected previously from six Holstein calves and six Barbarine sheep at the National School of Veterinary Medicine of Sidi Thabet, Tunisia, were analyzed. Laboratory work was conducted at the National Gene Bank of Tunisia in 2026. DNA was extracted using a modified cetyltrimethylammonium bromide (CTAB) procedure incorporating liquid-nitrogen pretreatment. A TaqMan real-time PCR assay targeting the COWP gene was performed with an internal process control (IPC). An exploratory DNA concentration series was also examined.

Result: Three of the 12 samples showed amplification meeting the operational cycle-threshold criterion (Ct < 40). The samples originated from two calves aged 7 and 10 days and one 10-day-old sheep, with Ct values of 33.85, 35.81 and 38.80, respectively. All three animals had recorded diarrhea. Four samples from clinically normal sheep were negative. The concentration-series observations did not establish a formal analytical limit of detection or complete analytical validation. In the absence of independent molecular confirmation, definitive species identification could not be established.

Cryptosporidium is a genus of apicomplexan parasites that infect the gastrointestinal tract of humans and a wide range of animals. Infection may cause diarrhea, with clinical severity influenced by factors including host age, immune status, parasite species and infection intensity. Young ruminants are of particular interest because enteric disease can affect animal health and farm productivity. Some Cryptosporidium species are zoonotic, making accurate detection and characterization relevant to veterinary and public health (Fayer, 2004; Ryan et al., 2014; Ryan et al., 2021). Studies in young ruminants have also documented the occurrence of Cryptosporidium and used molecular approaches to characterize the detected species, highlighting the relevance of age-specific investigations and molecular confirmation (Dixit et al., 2018; Swain et al., 2018).
       
Recent studies continue to document the occurrence and zoonotic potential of Cryptosporidium spp. in different animal hosts. For example, Jian et al., (2025) investigated Cryptosporidium spp. and Enterocytozoon bieneusi in dogs and cats, while Mishra et al., (2025) examined naturally occurring Cryptosporidium spp. infections in goats. These studies highlight the importance of investigating the parasite in different animal populations and epidemiological contexts.
       
The diagnosis of cryptosporidiosis may involve microscopic examination, antigen detection and molecular methods. Polymerase chain reaction (PCR)-based approaches are increasingly used in veterinary investigations for the molecular detection of infectious agents, including multiplex PCR assays developed for the diagnosis of infections in cattle (Narwade et al., 2026). Real-time PCR (qPCR) offers a sensitive approach for detecting target nucleic acids and can be used in diagnostic workflows. TaqMan assays use a sequence-specific fluorescent probe, allowing amplification to be monitored during the reaction. The performance of such assays, however, depends on the target selected, primer and probe specificity, sample preparation, the presence of inhibitors and the quality of analytical validation. The diagnostic performance of molecular methods can be influenced by fecal-matrix inhibitors, DNA extraction procedures and the analytical characteristics of the assay; consequently, the choice of diagnostic method should be considered when interpreting results from animal samples (Aboelsoued and Abdel, 2022).
       
The Cryptosporidium oocyst wall protein gene (COWP) has been used as a molecular target in diagnostic assays. Several genetic targets have been used for the molecular detection and characterization of Cryptosporidium, including the COWP gene and the small-subunit ribosomal RNA (18S rRNA) gene. The suitability of a target depends on the diagnostic objective, the sequence region selected and the ability of the assay to detect or differentiate the species of interest (Xiao et al., 2004; Ryan et al., 2014). Shin et al., (2018) described a multiplex real-time PCR approach targeting several intestinal parasites and incorporating an internal control. Nevertheless, amplification of a COWP-associated target should not automatically be interpreted as definitive identification of Cryptosporidium parvum in the absence of appropriate evidence for species specificity or independent confirmation.
       
Fecal samples also present methodological challenges for molecular analysis. Their composition may vary considerably and substances present in feces can interfere with nucleic-acid amplification. An internal amplification control can help identify possible inhibition, although its interpretation depends on how the control is introduced and measured. Sample extraction procedures and analytical controls therefore need to be considered when interpreting qPCR results. The present study was designed as an exploratory evaluation of a TaqMan real-time PCR assay targeting the COWP gene in fecal samples collected from young cattle and sheep in Tunisia, including animals with diarrhea and clinically normal sheep.
       
The objectives were to examine whether target amplification could be detected in these samples, document the corresponding cycle-threshold values and describe the results of the internal control and an exploratory concentration series. The study was not designed to estimate population prevalence or to establish a complete analytical validation of the assay.
Study design and fecal samples
 
This exploratory investigation was conducted in 2026 at the National Gene Bank of Tunisia using 12 fecal samples previously collected at the National School of Veterinary Medicine of Sidi Thabet, Tunisia. The samples comprised six male Holstein calves aged 2-10 days and six Barbarine sheep aged 7-120 days. According to the original clinical questionnaires, eight animals presented with diarrhea, whereas four sheep (samples 1, 2, 11 and 12) had no reported clinical signs and were recorded as clinically normal. Additional clinical observations included yellow diarrhea in calf sample 4 and bloody diarrhea in calf sample 6. The molecular analyses were conducted at the National Gene Bank of Tunisia. The individual sample characteristics and corresponding PCR results are presented in Table 1.

Table 1: Characteristics of the fecal samples and results of the COWP-targeting TaqMan real-time PCR assay.


 
DNA extraction and internal control
 
DNA extraction was performed using a modified cetyltrimethylammonium bromide (CTAB) protocol adapted from Doyle and Doyle (1987), with modifications to accommodate fecal samples. Liquid-nitrogen pretreatment was incorporated into the extraction procedure.
       
An internal process control (IPC) was added before DNA extraction. For this purpose, 5 µL of the control preparation at 0.2 ng/µL was added to each sample. The IPC was subsequently monitored during real-time PCR to assess whether amplification of the control target could be detected in the extracts.
       
A separate reference control containing a known quantity of DNA was processed through the extraction procedure. DNA concentration was assessed using a NanoDrop spectrophotometer. Because this measurement does not specifically quantify the IPC target or Cryptosporidium DNA, it was not used to establish parasite-DNA recovery or IPC recovery. The IPC results were interpreted as evidence of control-target amplification rather than as a direct measure of extraction efficiency.
 
TaqMan real-time PCR assay
 
Real-time PCR was performed using a TaqMan assay targeting the Cryptosporidium oocyst wall protein (COWP) gene. The assay was based on the primer/probe approach described by Shin et al., (2018), with the target sequence referenced to GenBank accession AB089292.
The oligonucleotide sequences were as follows:
 
• Forward primer: CAA GGC CTC CAA TGT ATA CAA AC
 
•​ Reverse primer: CGA TTG CTT GGA CTG AAA TAC AG
 
•​ TaqMan probe: FAM-CCT GTC TGC CCT CCA GGT ACA  GTA TTA C-BHQ1
       
The assay was adapted to the reaction conditions and internal-control system used in the present study. Each reaction had a final volume of 20 µL and contained 4 µL of 5× HOT FIREPol Multiplex qPCR Mix with ROX, 2 µL of 10× Oligo/Probe Mix, 2 µL of 10× Universal IPC Oligo/Probe Mix, 2 ng of template DNA and nuclease-free water to the final volume.
       
The amplification program consisted of an initial step at 95°C for 10 min, followed by 40 cycles of denaturation at 95°C for 15 s and annealing/extension at 60°C for 60 s. Fluorescence was recorded during the extension step.
       
The initial real-time PCR analysis included the 12 fecal samples, a positive control containing C. parvum DNA, a no-template control (NTC) and an internal process control (IPC). A Ct value below 40 was used as the operational criterion for positive amplification. Results were interpreted in conjunction with the available controls and the exploratory design of the study.
       
Additional laboratory procedures were performed on selected samples and included further DNA extraction, PCR analyses and evaluation of the internal process control (IPC). These complementary procedures were conducted to further examine the performance of the assay and the amplification of the target and control sequences. The positive control containing C. parvum DNA was used to monitor target amplification, while the no-template control (NTC) was included to monitor potential contamination. The results presented in this study are based on the initial PCR analysis, with the additional laboratory procedures providing complementary information on the assay and internal control performance.
 
Exploratory concentration series
 
A concentration series was examined to observe amplification across the tested DNA concentrations. The available concentration and Ct records are presented in Table 2. These observations are reported descriptively. Because the underlying calibration output needed to independently verify the regression statistics and analytical detection limit is not available for this version of the manuscript, the concentration series is not used here to claim a fully established analytical limit of detection, amplification efficiency, or linearity.

Table 2: Available observations from the exploratory DNA concentration series.


 
Data analysis
 
The results were summarized descriptively. The number and proportion of samples showing target amplification were calculated for the complete sample set and separately for calves and sheep. These proportions represent the observed amplification results in the 12 samples analyzed and were not interpreted as estimates of infection prevalence in the wider animal populations. Given the small sample size and exploratory study design, no inferential statistical analysis or population-level prevalence estimate was attempted.
Detection of the COWP-associated target
 
Amplification meeting the study’s operational Ct criterion (Ct < 40) was observed in three of the 12 fecal samples (25%). The positive samples originated from two Holstein calves aged 7 and 10 days and one Barbarine sheep aged 10 days, with Ct values of 33.85, 35.81 and 38.80, respectively (Table 1). All three positive samples came from animals with recorded diarrhea. The four samples obtained from sheep without reported clinical signs were negative. These findings describe the amplification results observed in the sampled animals and do not establish a causal relationship between the detected target and diarrhea. Moreover, amplification with the COWP-targeting assay does not independently confirm the identity of the detected organism at the species level. The diversity of Cryptosporidium species and genotypes reported in humans and animals reinforces the importance of appropriate molecular confirmation when species-level identification is intended (Fayer, 2004; Ryan et al., 2014). Previous studies have investigated Cryptosporidium in young ruminants using different diagnostic and molecular approaches, including molecular characterization in goat kids (Dixit et al., 2018) and buffalo calves (Swain et al., 2018). More recently, Mishra et al., (2025) documented Cryptosporidium infection in goats, further illustrating the continued veterinary relevance of this parasite. However, differences in host species, sample sizes, sampling strategies and diagnostic methods preclude direct comparison of these findings with the amplification proportions observed in the present exploratory sample set.
       
Within the six calf samples, two showed amplification (33.3%). Within the six sheep samples, one showed amplification (16.7%). These proportions describe only the animals included in this small sample set. They should not be interpreted as estimates of infection prevalence in the wider cattle or sheep populations in Tunisia.
       
The observed Ct values were relatively high, particularly for sample 9. A Ct value reflects the point at which fluorescence crosses the defined threshold under a particular assay setup; it should not be interpreted directly as a measure of parasite burden without an appropriate calibration and validation framework. The results are therefore reported as observed amplification values rather than as quantitative estimates of parasite load. The positive control showed amplification, whereas the no-template control (NTC) showed no amplification.
 
Internal process control results
 
The internal process control (IPC) yielded Ct values ranging from 17.3 to 20.7 across the extracts. Detection of the IPC indicates that the control target could be amplified in the tested reactions. These results provide useful information when considering possible amplification inhibition.
       
However, the IPC results do not, by themselves, establish the extraction efficiency for Cryptosporidium oocysts or demonstrate the recovery of parasite DNA from feces. Such conclusions would require a suitable extraction control design and a documented recovery assessment. The separate reference-control recovery estimates obtained from NanoDrop measurements are not interpreted as direct measurements of IPC recovery.
 
Interpretation of the exploratory concentration series
 
The available concentration series showed recorded Ct values across several DNA concentrations, as reported in Table 2. The lowest concentration tested, 0.002 ng/µL, was recorded as not detected (ND), whereas amplification was observed at concentrations of 0.004 ng/µL and above. These findings describe the amplification pattern under the conditions tested but do not establish a formal analytical limit of detection. Such a limit requires a defined validation procedure, sufficient replicate testing at relevant low concentrations and documented detection criteria. Similarly, amplification efficiency, linearity, slope and coefficient of determination cannot be reliably established without the underlying calibration data and appropriate statistical analysis. Accordingly, the concentration-series results are interpreted descriptively and are not used to claim a validated analytical limit of detection or complete analytical performance.
 
Assay specificity and species-level interpretation
 
The assay targeted the COWP gene and included a positive control containing C. parvum DNA. However, the use of this target and positive control does not establish species-specific detection of C. parvum. The primer/probe set used in this study was not experimentally assessed against other Cryptosporidium species or relevant non-target organisms. Furthermore, no independent molecular confirmation, sequencing, or parallel assay targeting a second locus was available for the three positive fecal samples. Accordingly, the results are interpreted as amplification of the COWP-associated target and cannot be considered definitive species-level identification or used to distinguish C. parvum from other Cryptosporidium species.
       
Future investigations should include an independent molecular target, such as a suitably validated 18S rRNA assay and/or sequencing of the relevant amplicon, where appropriate. The specificity of the assay should also be assessed against relevant non-target organisms. The 18S rRNA gene is widely used in Cryptosporidium molecular studies because it contains conserved and variable regions that can support detection and taxonomic characterization. However, its suitability for species discrimination depends on the selected region, primer design and analytical approach. Therefore, an 18S rRNA assay would provide an independent line of evidence but would not automatically guarantee species-level identification.
 
Methodological considerations and study limitations
 
The modified CTAB extraction procedure was used to obtain DNA from fecal material, with liquid-nitrogen pretreatment and an internal process control (IPC) added before DNA extraction. Although CTAB-based extraction methods have been widely used for nucleic-acid isolation, the resistance of Cryptosporidium oocysts to disruption makes it important to assess extraction performance specifically for this organism. The present data do not establish that the extraction procedure achieves a particular level of oocyst disruption or parasite-DNA recovery. The recovery of amplifiable DNA from fecal samples can be affected by the efficiency of oocyst disruption, the quality of the extracted nucleic acids and the presence of substances that inhibit PCR. These factors should therefore be considered when evaluating molecular detection workflows for Cryptosporidium (Jiang et al., 2005; Aboelsoued and Abdel, 2022).
       
The study has several limitations. First, the sample set comprised only 12 animals, which restricts the generalizability of the observed proportions. Second, the positive results were not independently confirmed using a second molecular target or sequencing. Third, the available concentration-series records do not provide a sufficient basis for reporting a complete set of analytical validation parameters. Finally, the sample set included animals with diarrhea and four sheep without reported clinical signs and the study was not designed to assess causal relationships between the detected target and clinical disease.
       
Despite these limitations, the investigation documents the application of a COWP-targeting TaqMan real-time PCR workflow to fecal samples from young cattle and sheep in Tunisia. The findings provide preliminary observations that may inform the design of a larger and more comprehensive evaluation.
In this exploratory study, a TaqMan real-time PCR assay targeting the COWP gene produced detectable amplification in three of 12 fecal samples collected from young ruminants in Tunisia. All three positive samples originated from animals with recorded diarrhea. The internal process control (IPC) yielded Ct values ranging from 17.3 to 20.7 across the extracts, indicating amplification of the control target but not establishing the efficiency of Cryptosporidium oocyst disruption or parasite-DNA recovery. The results demonstrate the feasibility of obtaining target amplification under the conditions used in this investigation, but they do not establish definitive species identification, population prevalence, or complete analytical validation. Further studies should include larger sample sets, independent molecular confirmation, systematic assessment of analytical specificity and a fully documented validation of analytical performance.
The authors would like to express their sincere gratitude to the National Gene Bank of Tunisia, under the supervision of the Ministry of Environment of Tunisia and to the National School of Veterinary Medicine of Sidi Thabet, University of Manouba, Tunisia, for their institutional support and for providing the facilities and resources that contributed to the completion of this study.
 
Disclaimers
 
The views and conclusions expressed in this article are solely those of the authors and do not necessarily represent the views of their affiliated institutions. The authors are responsible for the accuracy and completeness of the information provided, but do not accept any liability for any direct or indirect losses resulting from the use of this content.
 
Informed consent
 
Not applicable.
The authors declare that there are no conflicts of interest regarding the publication of this article. No funding or sponsorship influenced the design of the study, data collection, analysis, decision to publish, or preparation of the manuscript.

  1. Aboelsoued, D. and Abdel, M.K.N. (2022). Diagnosis and control of cryptosporidiosis in farm animals. Journal of Parasitic Diseases. 46(4): 1133-1146. doi: 10.1007/s12639-022-01513-2.

  2. Dixit, P., Rao, M.L.V., Dixit, A.K., Gupta, R. and Shukla, P.C. (2018). Prevalence and molecular characterisation of Cryptosporidium spp. in goat kids. Indian Journal of Animal Research. 53(9): 1234-1238. doi: 10.18805/ijar.B-3642.

  3. Doyle, J.J. and Doyle, J.L. (1987). A rapid DNA isolation procedure for small quantities of fresh leaf tissue. Phytochemical Bulletin. 19(1): 11-15.

  4. Fayer, R. (2004). Cryptosporidium: A water-borne zoonotic parasite. Veterinary Parasitology. 126(1-2): 37-56. doi: 10.1016/ j.vetpar.2004.09.004.

  5. Jiang, J., Alderisio, K.A., Singh, A. and Xiao, L. (2005). Development of procedures for direct extraction of Cryptosporidium DNA from water concentrates and for relief of PCR inhibitors. Applied and Environmental Microbiology. 71(3): 1135-1141. doi: 10.1128/AEM.71.3.1135-1141.2005.

  6. Jian, Y., Liu, S., Han, Q., Song, J., Li, P., Gao, Y., Tu, Y. and Luo, H. (2025). Occurrence and zoonotic evaluation of Cryptosporidium spp. and Enterocytozoon bieneusi in dogs and cats in Wenzhou, Southern China. Indian Journal of Animal Research. 59(8): 1381-1387. doi: 10.18805/IJAR.BF-1987.

  7. Mishra, V.K., Singh, S., Patel, S.K. et al. (2025). Prevalence, risk factors and haemato-biochemical alterations associated with naturally occurring Cryptosporidium spp. infection in goats. Indian Journal of Animal Research. doi: 10.18805/IJAR.B-5641.

  8. Narwade, P.S., Kumar, R.P., Kumar, P.P., Balamurugan, B., Jena, D., Ravi, K.S., Mishra, M.R., Ghosh, M. and Kumar, A. (2026). Prevalence of uterine infections and development of a multiplex PCR assay for their detection in cattle. Indian Journal of Animal Research. 60(2): 292-299. doi: 10.18805/IJAR.B-5720.

  9. Ryan, U., Fayer, R. and Xiao, L. (2014). Cryptosporidium species in humans and animals: Current understanding and research needs. Parasitology. 141(13): 1667-1685. doi: 10.1017/S0031182014001085.

  10. Ryan, U., Zahedi, A., Feng, Y. and Xiao, L. (2021). An update on zoonotic Cryptosporidium species and genotypes in humans. Animals. 11(11): 3307. doi: 10.3390/ani11113307.

  11. Shin, J.H., Lee, S.E., Kim, T.S., Ma, D.W., Cho, S.H., Chai, J.Y. and Shin, E.H. (2018). Development of molecular diagnosis using multiplex real-time PCR and T4 phage internal control to simultaneously detect Cryptosporidium parvum, Giardia lamblia and Cyclospora cayetanensis from human stool samples. The Korean Journal of Parasitology. 56(5): 419-427. doi: 10.3347/kjp.2018.56. 5.419.

  12. Swain, K., Vohra, S., Sangwan, A.K., Routray, A., Panigrahi, S. and Ganguly, S. (2018). Prevalence and molecular characterization of Cryptosporidium species in buffalo calves of western Haryana. Indian Journal of Animal Research. 53(5): 667-671. doi: 10.18805/ijar.B-3568.

  13. Xiao, L., Fayer, R., Ryan, U. and Upton, S.J. (2004). Cryptosporidium taxonomy: Recent advances and implications for public health. Clinical Microbiology Reviews. 17(1): 72-97. doi: 10.1128/CMR.17.1.72-97.2004.
In this Article
Published In
Indian Journal of Animal Research

Editorial Board

View all (0)